JP2022528840A5 - - Google Patents

Info

Publication number
JP2022528840A5
JP2022528840A5 JP2021557374A JP2021557374A JP2022528840A5 JP 2022528840 A5 JP2022528840 A5 JP 2022528840A5 JP 2021557374 A JP2021557374 A JP 2021557374A JP 2021557374 A JP2021557374 A JP 2021557374A JP 2022528840 A5 JP2022528840 A5 JP 2022528840A5
Authority
JP
Japan
Prior art keywords
formula
modified
bond
group
subunit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021557374A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022528840A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/025017 external-priority patent/WO2020198509A2/en
Publication of JP2022528840A publication Critical patent/JP2022528840A/ja
Publication of JP2022528840A5 publication Critical patent/JP2022528840A5/ja
Priority to JP2025015181A priority Critical patent/JP2025072451A/ja
Pending legal-status Critical Current

Links

JP2021557374A 2019-03-26 2020-03-26 安定性が増加した修飾オリゴヌクレオチド Pending JP2022528840A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025015181A JP2025072451A (ja) 2019-03-26 2025-01-31 安定性が増加した修飾オリゴヌクレオチド

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962824136P 2019-03-26 2019-03-26
US62/824,136 2019-03-26
US201962826454P 2019-03-29 2019-03-29
US62/826,454 2019-03-29
US201962864792P 2019-06-21 2019-06-21
US62/864,792 2019-06-21
PCT/US2020/025017 WO2020198509A2 (en) 2019-03-26 2020-03-26 Modified oligonucleotides with increased stability

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025015181A Division JP2025072451A (ja) 2019-03-26 2025-01-31 安定性が増加した修飾オリゴヌクレオチド

Publications (2)

Publication Number Publication Date
JP2022528840A JP2022528840A (ja) 2022-06-16
JP2022528840A5 true JP2022528840A5 (enExample) 2023-04-03

Family

ID=72609530

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021557374A Pending JP2022528840A (ja) 2019-03-26 2020-03-26 安定性が増加した修飾オリゴヌクレオチド
JP2025015181A Pending JP2025072451A (ja) 2019-03-26 2025-01-31 安定性が増加した修飾オリゴヌクレオチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025015181A Pending JP2025072451A (ja) 2019-03-26 2025-01-31 安定性が増加した修飾オリゴヌクレオチド

Country Status (4)

Country Link
US (2) US11820985B2 (enExample)
EP (1) EP3946369A4 (enExample)
JP (2) JP2022528840A (enExample)
WO (1) WO2020198509A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3929293A3 (en) 2015-04-03 2022-03-16 University Of Massachusetts Fully stabilized asymmetric sirna
WO2017030973A1 (en) 2015-08-14 2017-02-23 University Of Massachusetts Bioactive conjugates for oligonucleotide delivery
WO2017132669A1 (en) 2016-01-31 2017-08-03 University Of Massachusetts Branched oligonucleotides
WO2018031933A2 (en) 2016-08-12 2018-02-15 University Of Massachusetts Conjugated oligonucleotides
CN106987604B (zh) * 2017-03-29 2021-05-28 北京希诺谷生物科技有限公司 一种制备动脉粥样硬化疾病模型犬的方法
WO2018237245A1 (en) 2017-06-23 2018-12-27 University Of Massachusetts TWO TAIL SELF-ADMINISTRATION SIRNA AND ASSOCIATED METHODS
EP3781677A4 (en) 2018-04-16 2022-01-19 University of Massachusetts COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITTING
BR112021002440A2 (pt) 2018-08-10 2021-05-04 University Of Massachusetts oligonucleotídeos modificados visando snps
WO2020041769A1 (en) 2018-08-23 2020-02-27 University Of Massachusetts O-methyl rich fully stabilized oligonucleotides
CN113614232A (zh) 2019-01-18 2021-11-05 马萨诸塞大学 动态药代动力学修饰锚
EP3946369A4 (en) 2019-03-26 2023-10-18 University Of Massachusetts MODIFIED OLIGONUCLEOTIDES WITH INCREASED STABILITY
KR20220047989A (ko) 2019-08-09 2022-04-19 유니버시티 오브 매사추세츠 Snp를 표적화하는 화학적으로 변형된 올리고뉴클레오타이드
US12365894B2 (en) 2019-09-16 2025-07-22 University Of Massachusetts Branched lipid conjugates of siRNA for specific tissue delivery
US12339155B2 (en) 2020-03-25 2025-06-24 Kuwana Metals, Ltd. Sensor
AU2021244600A1 (en) 2020-03-26 2022-11-03 University Of Massachusetts Synthesis of modified oligonucleotides with increased stability
CA3174079A1 (en) 2020-05-26 2021-12-02 Anastasia Khvorova Synthetic oligonucleotides having regions of block and cluster modifications
EP4158028A4 (en) 2020-05-28 2024-10-02 University Of Massachusetts OLIGONUCLEOTIDES FOR THE MODULATION OF SARS-COV-2
BR112023019981A2 (pt) 2021-03-29 2023-12-12 Alnylam Pharmaceuticals Inc Composições do agente irna de huntingtina (htt) e métodos de uso das mesmas
IL309334A (en) 2021-06-23 2024-02-01 Univ Massachusetts Anti-FLT1 optimized oligonucleotide compounds for the treatment of preeclampsia and other angiogenic disorders
US20240425853A1 (en) * 2021-07-22 2024-12-26 Microbio (Shanghai) Co. Ltd. Modified small interfering rna molecules with reduced off-target effects
CN115819484B (zh) * 2021-07-23 2026-06-02 苏州瑞博生物技术股份有限公司 双链寡核苷酸、含双链寡核苷酸的组合物与缀合物及制备方法和用途
WO2023069495A1 (en) * 2021-10-19 2023-04-27 Alnylam Pharmaceuticals, Inc. Oligonucleotides with 2'-deoxy-2'-f-2'-c-methyl nucleotides
WO2023081908A2 (en) 2021-11-08 2023-05-11 University Of Massachusetts Oligonucleotides for sod1 modulation
WO2023114989A2 (en) * 2021-12-17 2023-06-22 University Of Massachusetts Oligonucleotides for mlh3 modulation
US20240052344A1 (en) * 2022-05-04 2024-02-15 University Of Massachusetts Oligonucleotides for pms1 modulation
CN119487046B (zh) * 2022-06-27 2026-08-07 大睿生物医药科技(上海)有限公司 含有可降低脱靶毒性的核苷酸类似物的双链rna
WO2025264952A2 (en) * 2024-06-21 2025-12-26 Eli Lilly And Company Novel rna therapeutics and uses thereof
WO2026006109A2 (en) * 2024-06-24 2026-01-02 Eli Lilly And Company Novel rna therapeutics and uses thereof
WO2026080452A1 (en) * 2024-10-07 2026-04-16 Creyon Bio, Inc. Fluorosulfonyl phosphoramidate (fsp) backbone modification and uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610289A (en) 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
US5672697A (en) * 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
JPH0641183A (ja) 1992-07-23 1994-02-15 Mitsubishi Kasei Corp オリゴヌクレオチド単分子膜
US6291438B1 (en) 1993-02-24 2001-09-18 Jui H. Wang Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use
EP0691979A1 (en) 1993-03-31 1996-01-17 Sanofi Novel 5'-substituted nucleosides and oligomers produced therefrom
WO1996003500A1 (en) 1994-07-26 1996-02-08 Ltt Institute Co., Ltd. Sustance with antiviral activity
US6025335A (en) 1995-09-21 2000-02-15 Lipitek International, Inc. L-Nucleoside Dimer Compounds and therapeutic uses
US6242589B1 (en) * 1998-07-14 2001-06-05 Isis Pharmaceuticals, Inc. Phosphorothioate oligonucleotides having modified internucleoside linkages
US20100240730A1 (en) * 2002-02-20 2010-09-23 Merck Sharp And Dohme Corp. RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
EP1578754A4 (en) 2002-10-30 2006-07-19 Makscientific Llc ROTARY PHOSPHOLIPIDS SUBSTITUTED ANTIPROTOZOOSES
DE10326302A1 (de) 2003-06-11 2004-12-30 Gnothis Holding Sa Bi-Fluorophor-markierte Sonden zum Nachweis von Nukleinsäuren
US20050176045A1 (en) 2004-02-06 2005-08-11 Dharmacon, Inc. SNP discriminatory siRNA
JP2008504840A (ja) 2004-06-30 2008-02-21 アルニラム ファーマスーティカルズ インコーポレイテッド 非リン酸骨格結合を含むオリゴヌクレオチド
EP2342340A1 (en) * 2008-09-22 2011-07-13 Rxi Pharmaceuticals Corporation Rna interference in skin indications
US8309356B2 (en) 2009-04-01 2012-11-13 Yale University Pseudocomplementary oligonucleotides for targeted gene therapy
US8987222B2 (en) 2009-04-08 2015-03-24 University Of Massachusetts Single nucleotide polymorphism (SNP) targeting therapies for the treatment of huntington'S disease
ES2733708T3 (es) 2010-02-08 2019-12-02 Ionis Pharmaceuticals Inc Reducción selectiva de variantes alélicas
WO2011125943A1 (ja) 2010-04-01 2011-10-13 日本新薬株式会社 修飾オリゴヌクレオチド
JP2013545817A (ja) 2010-12-16 2013-12-26 バーテックス ファーマシューティカルズ インコーポレイテッド インフルエンザウイルス複製阻害物質
AU2011343647A1 (en) 2010-12-16 2013-05-02 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
RU2013132681A (ru) 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы репликации вирусов гриппа
GB201105137D0 (en) 2011-03-28 2011-05-11 Isis Innovation Therapeutic molecules for use in the suppression of Parkinson's disease
WO2012143796A2 (en) 2011-04-21 2012-10-26 Institut Pasteur Korea Anti-inflammation compounds
EP3007705A4 (en) 2013-06-12 2017-02-15 Oncoimmunin, Inc. Systemic in vivo delivery of oligonucleotides
CA2938084A1 (en) 2014-01-27 2015-07-30 The Board Of Trustees Of The Leland Stanford Junior University Oligonucleotides and methods for treatment of cardiomyopathy using rna interference
EP3137606A4 (en) 2014-05-01 2018-04-25 Larry J. Smith METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT
RS60762B1 (sr) * 2015-04-03 2020-10-30 Univ Massachusetts Oligonukleotidna jedinjenja za ciljane irnk hantingtina
WO2017132669A1 (en) * 2016-01-31 2017-08-03 University Of Massachusetts Branched oligonucleotides
WO2018041973A1 (en) 2016-09-01 2018-03-08 Proqr Therapeutics Ii B.V. Chemically modified single-stranded rna-editing oligonucleotides
US11603532B2 (en) 2017-06-02 2023-03-14 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof
BR112021002440A2 (pt) 2018-08-10 2021-05-04 University Of Massachusetts oligonucleotídeos modificados visando snps
EP3946369A4 (en) 2019-03-26 2023-10-18 University Of Massachusetts MODIFIED OLIGONUCLEOTIDES WITH INCREASED STABILITY
CN115605226A (zh) 2020-03-26 2023-01-13 纽特莱特公司(Us) 具有抗炎和生长促进活性的去乙酰基葡糖胺胞壁酰二肽的亲脂对映异构体
AU2021244600A1 (en) 2020-03-26 2022-11-03 University Of Massachusetts Synthesis of modified oligonucleotides with increased stability

Similar Documents

Publication Publication Date Title
AU2025259917A1 (en) Multi-targeted single entity conjugates
AU2022202011B2 (en) Short interfering nucleic acid (siNA) molecules containing a 2' internucleoside linkage
JP2019503394A5 (enExample)
JP6571663B2 (ja) 逆方向アプローチを使用した長いrnaの非常に効果的な合成
US9751909B2 (en) Synthesis and uses of nucleic acid compounds with conformationally restricted monomers
CN106795197B (zh) 改性寡核苷酸及其制备方法
JP2021503940A5 (enExample)
JP2023010836A (ja) エンドソーム切断可能なリンカー
KR20190044653A (ko) 4'-포스페이트 유사체 및 이를 포함하는 올리고뉴클레오타이드
EP2217612A1 (en) Preparation of nucleotide oligomer
IL108467A (en) Modified oligodeoxyribo-nucleotides their preparation and their therapeutic use
WO2025188589A1 (en) NOVEL NUCLEOTIDES AND OLIGONUCLEOTIDES AND RNAi AGENTS COMPRISING THE SAME
CN121729422A (zh) 含有核苷酸类似物的双链rna
EP4541804A1 (en) Cyclic phosphonate-modified nucleotide
CN118063535A (zh) 含氨基衍生结构的修饰核苷、寡聚核酸化合物及合成方法
US20250388617A1 (en) Double-stranded rna comprising nucleotide analog capable of reducing off-target toxicity
JPWO2006027862A1 (ja) ヌクレオシド類似体、およびそれを含むオリゴヌクレオチド類似体
CN120904263B (zh) 具有增加寡核苷酸体内稳定性的2'核糖修饰的核苷酸化合物及其合成方法与应用
CN121517477A (zh) 一种5´-末端膦酸化核苷酸的合成及其在寡核酸的应用
CN121471286A (zh) 一种5´-末端硫代膦酸化修饰的寡核酸的合成及其应用
CN121991148A (zh) 5´-末端硫代膦酸化核苷酸的合成及其在寡核酸的应用
CN121426855A (zh) 一种5´-末端磷酸化修饰的寡核酸的合成及其应用
WO2025191337A2 (en) Oligonucleotide terminal phosphate derivatives and method of use
RU2020118025A (ru) Нуклеиновая кислота, композиция и конъюгат, содержащие ее, а также способ их получения и применения
CN121449671A (zh) 一种末端硫代膦酸化修饰的苏糖核酸及其在寡核酸的应用